A Single Dose, Randomized, Open-label, Four-period, Replicate Crossover Bioequivalence Study of Generic Fixed Dose Combinations of Sacubitril/Valsartan 97/103 mg Film-coated Tablets and Reference Product (Entresto) in Healthy Thai Volunteers under Fasting Conditions

Authors
Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: b2592d3d9db7a5ab0ff14516c31886c49e44ff40
First added on: Apr 11, 2025